Women’s Oncology at Women & Infants’ earns 3-year accreditation
The American College of Surgeons Commission on Cancer recently announced that the Program in Women’s Oncology at Women & Infants Hospital of Rhode Island earned a three-year accreditation with commendation.
The announcement came as a result of a successful site visit in late September, according to Margaret M. Steinhoff, MD, chair of the hospital’s Cancer Committee.
“This accreditation with commendation is testimony to the quality of care available for women with cancer at the Program in Women’s Oncology, and the dedication and passion of the staff working here,” Dr. Steinhoff said in a statement.
The Commission on Cancer (CoC) lists five elements that are key to the success of a cancer program: State-of-the-art pretreatment evaluation, staging, treatment and clinical follow-up for cancer patients with primary, secondary, tertiary or end-of-life care; a Cancer Committee that leads the program through setting goals, monitoring activity, evaluating patient outcomes and improving care; Cancer conferences (Tumor Board at Women & Infants) that provide a forum for patient consultation and contribute to physician education; a quality improvement program that serves as a mechanism for evaluating and improving patient outcomes; and a cancer registry and database that serves as the basis for monitoring the quality of care.
The CoC will not even send a team out to evaluate a program if it does not meet certain criteria, including having a multidisciplinary approach to cancer care that includes diagnostic imaging, radiation oncology services, systemic therapy services, clinical trials, psychosocial support services, rehabilitation services and nutrition services.